[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content
Log in

Gene Editing and the Slippery Slope Argument: Should We Fix the Enhancement/Therapy Distinction as the Definitive Boundary?

  • Letter
  • Published:
Science and Engineering Ethics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

References

  • De Miguel Beriain, I. (2017). Legal issues regarding gene editing at the beginning of life: An EU perspective. Regenerative Medicine, 12(6), 669–679.

    Article  Google Scholar 

  • Walton, D. (2016). The slippery slope argument in the ethical debate on genetic engineering of humans. Science and Engineering Ethics, 23(6), 1507–1528.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iñigo de Miguel Beriain.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Miguel Beriain, I. Gene Editing and the Slippery Slope Argument: Should We Fix the Enhancement/Therapy Distinction as the Definitive Boundary?. Sci Eng Ethics 25, 1257–1258 (2019). https://doi.org/10.1007/s11948-018-0048-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11948-018-0048-y

Navigation